Wanda Phipatanakul
Allergy & Immunology · Boston, MANPI 1952409005
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Sanofi at 32.7% of the total. Among allergy & immunology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 566 payments — averaging $1198.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$222K
- Regeneron Healthcare Solutions, Inc.$166K
- Genentech USA, Inc.$73K
- AstraZeneca$70K
- GSK$41K
- Regeneron$22K
- plus $84K from 16 others
Across 151 payments — averaging $16,663 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$938K
- Organon$555K
- Regeneron$525K
- GSK$343K
- Phadia US Inc.$95K
- Sanofi$24K
- plus $37K from 2 others
What the payments were for
- Consulting fees$174,91226%
- Speaking & faculty fees$375,62455%
- Grants$6,0001%
- Travel & lodging$112,58417%
- Food & beverage$9,5041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 113 | $221,639 |
| Regeneron Healthcare Solutions, Inc. | 198 | $166,230 |
| Genentech USA, Inc. | 65 | $73,405 |
| AstraZeneca | 60 | $70,261 |
| GSK | 48 | $41,160 |
| Regeneron | 7 | $21,795 |
| Novartis | 14 | $16,072 |
| Merck Kgaa | 2 | $13,849 |
| ARS Pharmaceuticals Operations, Inc. | 10 | $12,162 |
| Chiesi USA, Inc. | 4 | $8,466 |
| Astrazeneca AB | 3 | $7,250 |
| AbbVie | 14 | $6,331 |
| Teva Pharmaceuticals USA, Inc. | 2 | $4,930 |
| Sanofi-aventis U.S. LLC | 6 | $4,239 |
| Aero US Inc | 1 | $2,972 |
| Amgen | 2 | $2,100 |
| Circassia Inc. | 1 | $2,000 |
| Alk-abello, Inc | 10 | $1,698 |
| Astrazeneca UK Limited | 1 | $806 |
| Eli Lilly | 1 | $800 |
| EMD Serono, Inc. | 3 | $408 |
| Illuminoss Medical, Inc. | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$279,707
- XOLAIR$65,773
- TEZSPIRE$51,700
- NUCALA$35,313
- AIRSUPRA$13,617
- NEFFY$12,116
- Rinvoq$5,997
- AEROGEN SOLO NEBULIZER SYSTEM$5,944
- ProAir Digihaler$4,930
- NO PRODUCT DISCUSSED$3,291
- AEROGEN USB CONTROLLER SYSTEM$2,972
- AEROGEN SOLO; AEROGEN ULTRA$2,972
- NIOX$2,000
- ArmonAir Digihaler$1,680
- AirDuo RespiClick$1,680
- Odactra$1,000
- Grastek$1,000
- Ragwitek$1,000
- FASENRA$118
- ILARIS$103
How this compares
$678,624 in reported general payments places this provider in the 95th percentile of 114 allergy & immunology providers in Massachusetts.
Other allergy & immunology in Boston
- Kathleen BuchheitBoston$224K
- Aleena BanerjiBoston$133K
- Jeffrey GelfandBoston$84K
- Paul MaglioneBoston$66K
- Matthew GiannettiBoston$55K
- Aidan LongBoston$43K
- Wayne MarascoBoston$40K
- Michael PistinerBoston$36K
- Jocelyn FarmerBoston$32K
- Christopher ChuBoston$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.